Acetylfentanyl
Synthetic opioid analgesic
Acetylfentanyl | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 3258-84-2 |
PubChem | 62157 |
DrugBank | |
ChemSpider | 55980 |
KEGG |
Acetylfentanyl is a synthetic opioid analgesic that is an analog of fentanyl. It is a potent agonist of the mu-opioid receptor and has been associated with numerous overdose deaths.
Chemical structure and properties
Acetylfentanyl is chemically similar to fentanyl, with the primary difference being the presence of an acetyl group in place of the propionyl group found in fentanyl. Its IUPAC name is N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide. The molecular formula is C21H26N2O.
Pharmacology
Acetylfentanyl acts as a potent agonist at the mu-opioid receptor, which is responsible for its analgesic and euphoric effects. It is estimated to be 5 to 15 times more potent than heroin and about 80 times more potent than morphine. The drug's high potency increases the risk of overdose and respiratory depression.
Medical use
Acetylfentanyl has no approved medical use and is not prescribed for any condition. It is often encountered as a designer drug and is sometimes found in illicit drug supplies, either alone or mixed with other substances.
Legal status
The legal status of acetylfentanyl varies by country. In many jurisdictions, it is classified as a controlled substance due to its high potential for abuse and lack of accepted medical use. For example, in the United States, it is classified as a Schedule I substance under the Controlled Substances Act.
Health risks
The primary health risks associated with acetylfentanyl are related to its potency and potential for overdose. Symptoms of overdose may include severe respiratory depression, sedation, coma, and death. Naloxone can be used to reverse the effects of an acetylfentanyl overdose, but multiple doses may be required due to the drug's potency.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD